145 related articles for article (PubMed ID: 27267842)
1. miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer.
Das DK; Osborne JR; Lin HY; Park JY; Ogunwobi OO
Transl Oncol; 2016 Jun; 9(3):236-41. PubMed ID: 27267842
[TBL] [Abstract][Full Text] [Related]
2. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
3. Small Extracellular Vesicle-Derived microRNAs Stratify Prostate Cancer Patients According to Gleason Score, Race and Associate with Survival of African American and Caucasian Men.
Ali HEA; Gaballah MSA; Gaballa R; Mahgoub S; Hassan ZA; Toraih EA; Drake BF; Abd Elmageed ZY
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680382
[TBL] [Abstract][Full Text] [Related]
4. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
5. TUMOR MICROENVIRONMENT-ASSOCIATED miR-7-5p, miR-19a-3p, AND miR-23b-3p EXPRESSION IN PROSTATE CANCER WITH DIFFERENT PROGRESSION RISK.
Borikun T; Mushii O; Pavlova A; Burda T; Zadvornyi T
Exp Oncol; 2024 Feb; 45(4):432-442. PubMed ID: 38328847
[TBL] [Abstract][Full Text] [Related]
6. microRNA Expression Profiling in Young Prostate Cancer Patients.
Valera VA; Parra-Medina R; Walter BA; Pinto P; Merino MJ
J Cancer; 2020; 11(14):4106-4114. PubMed ID: 32368293
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
8. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.
Rane JK; Scaravilli M; Ylipää A; Pellacani D; Mann VM; Simms MS; Nykter M; Collins AT; Visakorpi T; Maitland NJ
Eur Urol; 2015 Jan; 67(1):7-10. PubMed ID: 25234358
[TBL] [Abstract][Full Text] [Related]
12. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
Guan Y; Wu Y; Liu Y; Ni J; Nong S
Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.
Duca RB; Massillo C; Farré PL; Graña KD; Moro J; Gardner K; Lacunza E; De Siervi A
Front Oncol; 2022; 12():997457. PubMed ID: 36387263
[TBL] [Abstract][Full Text] [Related]
14. MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer.
Matsuzaki K; Fujita K; Tomiyama E; Hatano K; Hayashi Y; Wang C; Ishizuya Y; Yamamoto Y; Hayashi T; Kato T; Jingushi K; Kawashima A; Ujike T; Nagahara A; Uemura M; Tsujikawa K; Nonomura N
Transl Androl Urol; 2021 Apr; 10(4):1918-1927. PubMed ID: 33968679
[TBL] [Abstract][Full Text] [Related]
15. MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis.
Duca RB; Massillo C; Dalton GN; Farré PL; Graña KD; Gardner K; De Siervi A
Am J Cancer Res; 2021; 11(6):2802-2820. PubMed ID: 34249429
[TBL] [Abstract][Full Text] [Related]
16. Combinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer.
Feng S; Qian X; Li H; Zhang X
Oncol Lett; 2017 Dec; 14(6):6943-6949. PubMed ID: 29163712
[TBL] [Abstract][Full Text] [Related]
17. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
18. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.
Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; Oliveira J; Henrique R; Jerónimo C
Front Oncol; 2019; 9():900. PubMed ID: 31572685
[TBL] [Abstract][Full Text] [Related]
19. miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression.
Epis MR; Giles KM; Beveridge DJ; Richardson KL; Candy PA; Stuart LM; Bentel J; Cohen RJ; Leedman PJ
Oncotarget; 2017 Aug; 8(33):55116-55134. PubMed ID: 28903407
[TBL] [Abstract][Full Text] [Related]
20. Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.
Zhang H; Lian Z; Sun G; Liu R; Xu Y
Onco Targets Ther; 2018; 11():3853-3867. PubMed ID: 30013366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
